Position in CELC
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$146,598,904
-$33,756,748 QoQ
Shares Held
1,284,378
-29.0% QoQ
Ownership
2.63%
of shares outstanding
% of Portfolio
5.83%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Soleus Capital Management, L.P. holds $1,422,770,178 across 59 Biotechnology names. CELC ranks #2 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KRYS |
Krystal Biotech, Inc.
|
1,153,087 | $297,865,433 | |
| 2 | CELC |
Celcuity Inc.
This page
|
1,284,378 | $146,598,904 | |
| 3 | TGTX |
Tg Therapeutics, Inc.
|
4,029,319 | $133,853,977 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
330,517 | $106,489,272 | |
| 5 | VCEL |
Vericel Corp
|
2,549,079 | $82,003,871 | |
| 6 | GERN |
Geron Corp
|
41,508,659 | $61,847,901 | |
| 7 | IMUX |
Immunic, Inc.
|
4,500,000 | $49,950,000 | |
| 8 | EWTX |
Edgewise Therapeutics, Inc.
|
1,449,915 | $45,672,322 |
All Filings in CELC
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $146,598,904 | 1,284,378 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $180,355,652 | 1,808,258 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $58,235,684 | 1,178,860 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $40,207,770 | 3,011,818 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $26,024,373 | 2,574,122 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $33,576,988 | 2,565,087 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $18,568,720 | 1,245,387 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $19,839,243 | 1,211,187 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $37,396,900 | 1,731,338 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $31,755,038 | 2,179,481 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $18,796,263 | 2,056,484 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $21,117,647 | 1,923,283 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $17,301,313 | 1,687,933 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,955,294 | 1,210,228 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,456,876 | 443,912 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,812,099 | 418,912 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $299,882 | 32,073 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $423,042 | 32,073 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,506,384 | 83,688 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $3,955,776 | 164,824 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||